Z79.632 Abrechenbarer, spezifischer Code Long term (current) use of antitumor antibiotic
ICD-10-CM Z79.632 identifies “Long term (current) use of antitumor antibiotic” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Kapitel 21: Factors influencing health status and contact with health services
Von der Angabe „bei Aufnahme vorhanden“ ausgenommen
Hinweise zum Code
Inclusion terms3
- Long term (current) use of bleomycin
- Long term (current) use of doxorubicin
- Long term (current) use of mitomycin C
Hinweise übergeordneter Ebenen
Kapitel 21 · Factors influencing health status and contact with health services (Z00-Z99)
Note3
- Z codes represent reasons for encounters. A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00-Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
- (a) When a person who may or may not be sick encounters the health services for some specific purpose, such as to receive limited care or service for a current condition, to donate an organ or tissue, to receive prophylactic vaccination (immunization), or to discuss a problem which is in itself not a disease or injury.
- (b) When some circumstance or problem is present which influences the person's health status but is not in itself a current illness or injury.
Z77-Z99 · Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
Code also1
any follow-up examination (Z08-Z09)
Z79 · Long term (current) drug therapy
Includes1
long term (current) drug use for prophylactic purposes
Excludes 22
- drug abuse and dependence (F11-F19)
- drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
Code also1
any therapeutic drug level monitoring (Z51.81)
Z79.6 · Long term (current) use of immunomodulators and immunosuppressants
Verweise im offiziellen Index
Verweise im offiziellen Index (4)
Long-term(current) (prophylactic) drug therapy (use of) (4)
- Long-term(current) (prophylactic) drug therapy (use of) › antitumor antibioticKrankheitsverzeichnis
- Long-term(current) (prophylactic) drug therapy (use of) › bleomycinKrankheitsverzeichnis
- Long-term(current) (prophylactic) drug therapy (use of) › doxorubicinKrankheitsverzeichnis
- Long-term(current) (prophylactic) drug therapy (use of) › mitomycin CKrankheitsverzeichnis
Offizielle Konversionshistorie
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Frühere Zuordnung: Z79.899
Verlauf
Codeverlauf
Letzte erfasste Änderung · FY2023
Gültig ab
- Hinzugefügt
Long term (current) use of antitumor antibiotic
Abrechenbarer Diagnosecode
CDC/NCHS · FY2023Alle Ausgaben (9)
| Alle Ausgaben | Gültig ab | Codeverlauf |
|---|---|---|
| FY2023 | 2022-10-01 | Hinzugefügt |
| FY2023 · 04-01 | 2023-04-01 | Keine tabellarische Änderung |
| FY2024 | 2023-10-01 | Keine tabellarische Änderung |
| FY2024 · 04-01 | 2024-04-01 | Keine tabellarische Änderung |
| FY2025 | 2024-10-01 | Keine tabellarische Änderung |
| FY2025 · 04-01 | 2025-04-01 | Keine tabellarische Änderung |
| FY2026 | 2025-10-01 | Keine tabellarische Änderung |
| FY2026 · April | 2026-04-01 | Keine tabellarische Änderung |
| FY2027 | 2026-10-01 | Keine tabellarische Änderung |
Dieser Eintrag ist ein vollständiger Code in der gewählten Ausgabe. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.